Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: WMT for Autism Spectrum Disorder (ASD) [Phase 1]

View source ↗

Summary

This document reports an ongoing Phase 1 clinical trial evaluating WMT for autism spectrum disorder, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WMT

Snippet

Sponsor: The Second Hospital of Nanjing Medical University | Conditions: Autism Spectrum Disorder | Phase 1 | Status: RECRUITING